Vogt Frederick G 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Iovance Interim CEO Frederick Vogt Receives RSUs; Tax Withholding
What Happened
Frederick G. Vogt, Interim CEO & General Counsel and a director of Iovance Biotherapeutics (IOVA), had 41,668 restricted stock units (RSUs) vest on June 1, 2026 and converted those RSUs into common stock (no exercise price). To satisfy mandatory tax withholding, 17,701 of the vested shares were withheld (reported as a disposition) at $3.96 per share, totaling $70,096. The net shares delivered to Vogt equal 41,668 − 17,701 = 23,967 (using the reported $3.96/share implies roughly $95k value for the net shares).
Key Details
- Transaction date: 2026-06-01; Form filed: 2026-06-03 (timely).
- Primary codes: M = conversion/exercise of derivative (RSU → shares); F = shares withheld to cover tax liability (not an open-market sale).
- Shares vested/converted: 41,668 RSUs → 41,668 shares.
- Shares withheld for taxes: 17,701 @ $3.96 = $70,096 (withheld by issuer).
- Net shares delivered to insider after withholding: 23,967.
- Footnotes: each RSU equals one share; remaining RSUs from the March 1, 2024 grant will vest in equal quarterly installments; withholding was mandatory and not an open-market sale.
Context
This was an award vesting and tax-withholding event (routine compensation processing), not a buy or open-market sale that signals trading sentiment. For retail investors: RSU vesting increases insider ownership when shares are delivered, but the withheld shares simply satisfy tax obligations and do not represent a market sale.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-01+41,668→ 571,206 total - Tax Payment
Common Stock
[F2][F3]2026-06-01$3.96/sh−17,701$70,096→ 553,505 total - Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]2026-06-01−41,668→ 125,007 total→ Common stock (41,668 underlying)
Footnotes (6)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.